The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Overall survival effect of lower chemotherapy dosing in extremely obese (BMI ≥ 35) patients with breast cancer based on adjusted BSA.
P. Sharma
No relevant relationships to disclose
T. A. Samuel
No relevant relationships to disclose
J. C. Wells
No relevant relationships to disclose
E. Mebel
No relevant relationships to disclose
J. T. French
No relevant relationships to disclose
J. A. Crozier
No relevant relationships to disclose
S. W. Looney
No relevant relationships to disclose